Stay updated on Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.

Latest updates to the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 removed; these are site versioning updates and do not affect the trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a government funding lapse notice with NIH status and updated the page to revision v3.4.1; removed a non-critical safety reference (Br J Dermatol 2025) and otherwise left study details intact. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedThe changes are minor UI/text updates, including capitalization tweaks and new labels such as 'Show glossary' and version information. They do not affect the study data, primary outcomes, or core content of the page.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 appears on the page, replacing the previous v3.3.3. This is a minor version update and does not alter the study details or content.SummaryDifference0.0%

- Check63 days agoChange DetectedAdditions establish a detailed list of study locations by state/province (e.g., Alabama, California, Ontario, etc.). A revision tag indicates the update (v3.3.3).SummaryDifference2%

- Check92 days agoChange DetectedAdditions clarify that publications are provided voluntarily by the enterer and are auto-filled from PubMed, with the Revision: v3.3.2 noted. Deletions remove older phrasings about the source and scope of PubMed listings (and the older Revision: v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.